« Return to News | Awards & Advancement

Pharmaron raises $40 million in financing round

Tuesday, March 1, 2011 08:42 AM

CRO Pharmaron Holding, of Irvine, Calif. and Beijing, has closed a Series C financing round totaling more than $40 million from existing investors DCM, Legend Capital and others, along with new investor GL Capital Group.

Pharmaron will use the new capital to strengthen and expand its drug discovery services offerings, preclinical GLP toxicology capabilities and GMP chemical synthesis services.

Pharmaron said it in 2010 became the first CRO in China to provide truly integrated drug discovery and development services from discovery to IND.

"Recently, the pharmaceutical and biotech industry has undergone fundamental changes as it has responded to increased productivity demands," said Pharmaron Chairman and CEO Dr. Boliang Lou. "Building long-term partnership with CROs has become part of many pharmaceutical and biotech companies' corporate strategy."




Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.